G-Therapeutics raised €26M in a Series A round in Apr 2016. The company is based in Eindhoven, Netherlands. Investors in the round: GIMV, INKEF Capital, LSP and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €26M
No source on record — unverified.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
